This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | |||
bacteria:t3e:xopl [2025/01/27 23:23] – [Biological function] jfpothier | bacteria:t3e:xopl [2025/02/13 12:36] (current) – jfpothier | ||
---|---|---|---|
Line 20: | Line 20: | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | XopL< | + | XopL< |
=== Regulation === | === Regulation === | ||
Line 34: | Line 34: | ||
* XopL//< | * XopL//< | ||
* XopL//< | * XopL//< | ||
- | * XopL//< | + | * XopL//< |
* Distantly related XopL homolog XopL//< | * Distantly related XopL homolog XopL//< | ||
- | * XopL//< | + | * XopL//< |
- | * XopL//< | + | * XopL//< |
- | * XopL//< | + | * XopL//< |
- | * XopL//< | + | * XopL//< |
* Transient expression of XopL//< | * Transient expression of XopL//< | ||
* //Xe //85-10 suppresses host autophagy by utilizing type-III effector XopL//< | * //Xe //85-10 suppresses host autophagy by utilizing type-III effector XopL//< | ||
Line 46: | Line 46: | ||
Several localization patterns have been reported for XopL proteins in epidermal cells with some strain dependent differences. XopLs are most often tagged at the C-terminus, with the exception of the studies by Leong //et al//., 2022 and Yan //et al.//, 2019. | Several localization patterns have been reported for XopL proteins in epidermal cells with some strain dependent differences. XopLs are most often tagged at the C-terminus, with the exception of the studies by Leong //et al//., 2022 and Yan //et al.//, 2019. | ||
- | * __Cytosolic localization__ | + | * __Cytosolic localization__ has been reported for XopL//< |
- | * __Nuclear localization__ | + | * __Nuclear localization__ was reported for XopL//< |
- | * __Plasma membrane localization__ | + | * __Plasma membrane localization__ has been reported for XopL< |
- | * __Microtubule localization__ | + | * __Microtubule localization__ has been reported for XopL//< |
- | * __Autophagosome localization__ | + | * __Autophagosome localization__ has been reported for XopL//< |
=== Enzymatic function === | === Enzymatic function === | ||
Line 63: | Line 63: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes (//e.g.//, //X. euvesicatoria//, | + | Yes (//e.g.//, //X. euvesicatoria//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Line 71: | Line 71: | ||
===== References ===== | ===== References ===== | ||
- | Adlung N (2016). Charakterisierung der Avirulenzaktivität von XopQ und Identifizierung möglicher Interaktoren von XopL aus // | + | Adlung N (2016). Charakterisierung der Avirulenzaktivität von XopQ und Identifizierung möglicher Interaktoren von XopL aus // |
- | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // | + | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // |
- | Huang J, Dong Y, Li N, He Y, Zhou H (2024a). The type III effector XopL//< | + | Huang J, Dong Y, Li N, He Y, Zhou H (2024a). The type III effector XopL//< |
- | Huang J, Zhou H, Zhou M, Li N, Jiang B, He Y (2024b). Functional analysis of type III effectors in // | + | Huang J, Zhou H, Zhou M, Li N, Jiang B, He Y (2024b). Functional analysis of type III effectors in // |
- | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | + | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // |
Leong JX, Raffeiner M, Spinti D, Langin G, Franz-Wachtel M, Guzman AR, Kim JG, Pandey P, Minina AE, Macek B, Hafrén A, Bozkurt TO, Mudgett MB, Börnke F, Hofius D, Üstün S (2022). A bacterial effector counteracts host autophagy by promoting degradation of an autophagy component. EMBO J. 41: e110352. DOI: [[https:// | Leong JX, Raffeiner M, Spinti D, Langin G, Franz-Wachtel M, Guzman AR, Kim JG, Pandey P, Minina AE, Macek B, Hafrén A, Bozkurt TO, Mudgett MB, Börnke F, Hofius D, Üstün S (2022). A bacterial effector counteracts host autophagy by promoting degradation of an autophagy component. EMBO J. 41: e110352. DOI: [[https:// | ||
- | Liu Y, Long J, Shen D, Song C (2016). // | + | Liu Y, Long J, Shen D, Song C (2016). // |
- | Ma W, Xu X, Cai L, Cao Y, Haq F, Alfano JR, Zu B, Zou L, Chen G (2020) | + | Ma W, Xu X, Cai L, Cao Y, Haq F, Alfano JR, Zu B, Zou L, Chen G (2020). A // |
- | Ortmann S, Marx J, Lampe C, Handrick V, Ehnert TM, Zinecker S, Reimers M, Bonas U, Erickson JL (2023). A conserved microtubule-binding region in // | + | Ortmann S, Marx J, Lampe C, Handrick V, Ehnert TM, Zinecker S, Reimers M, Bonas U, Erickson JL (2023). A conserved microtubule-binding region in // |
- | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | + | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // |
Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | ||
- | Soni M, Mondal KK. (2017). // | + | Soni M, Mondal KK. (2017). // |
- | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< | + | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< |
===== Acknowledgements ===== | ===== Acknowledgements ===== |